Similarly, an alternative approach to target cancer angiogenesis using an siRNA-based silencing approach was reported by Bharti and colleagues, who focused on IL-6/IL-6R and mitochondrial signaling in breast cancer. This evidence concerns the gene IL6 and breast carcinoma.